摘要:
L'objet de l'invention est une carte d'accès à un emplacement de stationnement dans un parc de stationnement, chaque emplacement étant référencé par une indication (12), ladite carte comportant une bande magnétique, caractérisée en ce qu'elle comprend sur l'une (14) de ses faces une compilation (16) desdites indications (12) recouverte par une couche (18) en matériau amagnétique, opaque et éliminable par abrasion, de sorte que le grattage partiel de ladite couche (18) permet de représenter l'indication (12) correspondant à l'emplacement occupé.
摘要:
The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).
摘要:
The invention encompasses the novel compound of Formula (I) as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula (I).
摘要:
The present invention provides novel compounds of Formula (I) and Formula (II), and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases (e.g., cancers (e.g.,leukemia, melanoma, multiple myeloma), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of a kinase, such as a cyclin-dependent kinase (CDK) (e.g., cyclin-dependent kinase 7 (CDK7)), and therefore, induce cellular apoptosis and/or inhibit transcription in the subject. (I)
摘要:
Heterocyclic compounds of structural formula I are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD). The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease; atherosclerosis; obesity; diabetes; neurological disease; Metabolic Syndrome; insulin resistance; cancer, liver steatosis; and non-alcoholic steatohepatitis.
摘要:
Azacycloalkane derivatives of structural formula I are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; and liver steatosis.
摘要:
L'objet de l'invention est une vis comprenant une empreinte (16) ayant des formes adaptées à l'extrémité d'un foret à béton comportant une pastille (26) disposée dans un plan médian longitudinal à son extrémité et de largeur L supérieure au diamètre du corps du foret caractérisée en ce que l'empreinte (16) comprend une partie inférieure (32) adaptée à l'extrémité du foret et une partie supérieure ou débouchante (34) comprenant selon un premier plan longitudinal médian (35.1) une dimension légèrement supérieure à la largeur L de la pastille (26) et selon un autre plan longitudinal médian (35.2) une dimension légèrement inférieure à la largeur L de la pastille (26) et supérieure au diamètre du corps du foret.
摘要:
The invention encompasses the novel compound of formula (I) as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).
摘要:
The present invention relates to a novel class of compounds mainly, substituted leucinamide-carboxylate derivatives of formula (I) wherein X is O or NR 9 , Y is CR 1 R 2 , -SO 2 , C=O or NR 9 ; Z is CR 1 R 2 , O, S, -SO 2 or NR 9 and each G is independently a CR 1 CR 2 and pharmaceutical compositions thereof. Said compounds are cathepsin cysteine protease inhibitors, including but not limited to, inhibitors of cathepsin K, L, S and B. These compounds are useful for treating and preventing cathpesin dependent conditions in which inhibition of bone resorption is indicated, such as osteoporosis.
摘要翻译:本发明涉及一类新的化合物,主要是式(I)的取代的亮氨酰胺羧酸酯衍生物,其中X是O或NR 9,Y是CR 1 R 2,-SO 2,C = O或NR 9; Z是CR 1 R 2,O,S,-SO 2或NR 9,每个G独立地是CR 1 CR 2及其药物组合物。 所述化合物是组织蛋白酶半胱氨酸蛋白酶抑制剂,包括但不限于组织蛋白酶K,L,S和B的抑制剂。这些化合物可用于治疗和预防其中指示骨吸收抑制如卡培他滨的依普林依赖性病症。
摘要:
The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).